Terms: = Skin cancer AND SSX4, MGC119056, 6759, ENSG00000204645, O60224, MGC12411 AND Treatment
4 results:
1. Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade.
Lotem M; Merims S; Frank S; Hamburger T; Nissan A; Kadouri L; Cohen J; Straussman R; Eisenberg G; Frankenburg S; Carmon E; Alaiyan B; Shneibaum S; Ozge Ayyildiz Z; Isbilen M; Mert Senses K; Ron I; Steinberg H; Smith Y; Shiloni E; Gure AO; Peretz T
J Immunol Res; 2016; 2016():8121985. PubMed ID: 27294163
[TBL] [Abstract] [Full Text] [Related]
2. Effects of CT-Xp gene knock down in melanoma cell lines.
Caballero OL; Cohen T; Gurung S; Chua R; Lee P; Chen YT; Jat P; Simpson AJ
Oncotarget; 2013 Apr; 4(4):531-41. PubMed ID: 23625514
[TBL] [Abstract] [Full Text] [Related]
3. EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors.
Neumann F; Kaddu-Mulindwa D; Widmann T; Preuss KD; Held G; Zwick C; Roemer K; Pfreundschuh M; Kubuschok B
Cancer Immunol Immunother; 2013 Jul; 62(7):1211-22. PubMed ID: 23619976
[TBL] [Abstract] [Full Text] [Related]
4. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.
dos Santos NR; Torensma R; de Vries TJ; Schreurs MW; de Bruijn DR; Kater-Baats E; Ruiter DJ; Adema GJ; van Muijen GN; van Kessel AG
Cancer Res; 2000 Mar; 60(6):1654-62. PubMed ID: 10749136
[TBL] [Abstract] [Full Text] [Related]